Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-01-24
DOI
10.1111/dom.13642
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4
- (2018) Jean-Daniel Lalau et al. DIABETES CARE
- Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease
- (2017) Zachary A. Marcum et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Renal Outcomes in Type 2 Diabetes
- (2017) Johannes F.E. Mann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study
- (2017) Christianne L. Roumie et al. Journal of the American Heart Association
- Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study
- (2017) Zhou Zhou et al. Diabetes Therapy
- Healthcare Resource Use, Costs, and Disease Progression Associated with Diabetic Nephropathy in Adults with Type 2 Diabetes: A Retrospective Observational Study
- (2017) Zhou Zhou et al. Diabetes Therapy
- Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline
- (2016) A. M. Hung et al. Clinical Journal of the American Society of Nephrology
- Metformin-associated risk of acute dialysis in patients with type 2 diabetes: A nationwide cohort study
- (2016) Nicholas Carlson et al. DIABETES OBESITY & METABOLISM
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort
- (2016) Martin Busch et al. BMC Nephrology
- Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
- (2015) David M. Charytan et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts
- (2015) Jiamei Lu et al. LIFE SCIENCES
- Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025
- (2015) Alexander Kainz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR
- (2015) Guideline development group et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study
- (2015) Szu-Chun Hung et al. Lancet Diabetes & Endocrinology
- Metformin in Patients With Type 2 Diabetes and Kidney Disease
- (2014) Silvio E. Inzucchi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register
- (2012) Nils Ekström et al. BMJ Open
- Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation
- (2011) Yong-nan Fu et al. ACTA PHARMACOLOGICA SINICA
- Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD
- (2011) Akshay S. Desai et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Metformin Use and Mortality Among Patients With Diabetes and AtherothrombosisMetformin Use With Diabetes and Atherothrombosis
- (2010) Ronan Roussel ARCHIVES OF INTERNAL MEDICINE
- Hypoglycemia, Diabetes, and Cardiovascular Events
- (2010) C. V. Desouza et al. DIABETES CARE
- Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study
- (2010) Stephen O Crawford et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started